Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 9, 2007, Pages 1347-1355

  Beutel, Julia ^a,b   Schroder, Christina ^a   von Hof, Katharina ^a   Rades, Dirk ^a   Kosmehl, Hartwig ^c   Wedel, Thilo ^d   Sieg, Peter ^a   Geerling, Gerd ^e   Hakim, Samer George ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Amifostine; Dry eye; Lidocaine; Pilocarpine; Radiation; Tear secretion

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMIFOSTINE; LIDOCAINE; PERTECHNETIC ACID TC 99M; PILOCARPINE; PILOMAN; TENASCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRY EYE; FEMALE; FUNCTIONAL MORPHOLOGY; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; LACRIMAL GLAND FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; SCHIRMER TEST; SCINTIGRAPHY; ULTRASTRUCTURE; UPREGULATION; X IRRADIATION;

ACTINS; AMIFOSTINE; ANIMALS; DRY EYE SYNDROMES; FEMALE; IMMUNOENZYME TECHNIQUES; LACRIMAL APPARATUS; LIDOCAINE; PILOCARPINE; RABBITS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RADIONUCLIDE IMAGING; TEARS; TENASCIN; UP-REGULATION; X-RAYS;

EID: 34548010052     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0548-y     Document Type: Article

References (21)

1. Göbbels M (1990) Das trockene Auge. Standortbestimmung und Aussichten. Fortschr Ophthalmol 87:190-197
2. Zettinig G, Hanselmayer G, Fueger BJ, Hofman A, Pirich C, Nepp J, Dudszak R (2002) Long-term impairment of the lacrimal glands after radioiodine therapy: A cross-sectional study. Eur J Nucl Med Mol Imaging 29:1428-1432
3. Bessell EM, Henck JM, Whitelocke RAF, Wright JE (1987) Ocular morbidity after radiotherapy of orbital and conjunctival lymphoma. Eye 1:90-96
4. MacFaul PA, Bedford MA (1970) Ocular complications after irradiation. Br J Ophthalmol 54:237-247
5. Schroder C, Hakim SG, Collin JR, Sieg P, Geerling G (2003) Long-term follow-up after autologous submandibular gland transplantation in scarring keratoconjunctivitis with absolute dry eyes. Ophthalmologe 100:1079-1084
6. Hakim SG, Kosmehl H, Lauer I, Nadrowitz R, Wedel T, Sieg P (2005) A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy. Cancer Res 65:10486-10493
7. Kumar S, Tyler AB, Philipps S, Burnet NG (1997) Oral pilocarpine improves radiotherapy-induced dry eyes. Clin Oncol 9:62-63
8. Hakim SG, Geerling G, Lauer I, Sieg P (2002) Scintigraphic evaluation of lacrimal glands using a rabbit experimental model. Ophthalmic Res 34:254-257
9. Stephens LC, Schultheiss TE, Ang KK, Peters LJ (1989) Pathogenesis of radiation injury to the salivary glands and potential methods of protection. Cancer Bull 41(2)
10. Letschert JGJ, González D, Oskam J, Koorneef L, van Dijk JD, Boukes R, Bras J, van Heerde P, Bartelink H (1991) Results of radiotherapy in patients with stage I orbital non-Hodgkins lymphoma. Radiother Oncol 22:36-44
11. Solans R, Bosch JA, Porta F, Roselló J, Selva-O'Callagan A, Vilardell M (2001) Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 42:738-743
12. Coppes RP, Vissink A, Zeilstra LJ, Konings AW (1997) Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol 72:615-625
13. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL 3rd, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjörgen syndrome: A randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159:174-181
14. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC (1993) Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390-395
15. Coppes RP, Zeilstra LJ, Kampinga HH, Konings AW (2001) Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 28:1055-1063
16. Roesink JM, Konings AW, Terhaard CH, Battermann JJ, Kampinga HH, Coppes RP (1999) Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: Radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys 45:483-489
17. Jones PL, Boudreau N, Myers CA, Erickson HP, Bissell MJ (1995) Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments. J Cell Sci 108:519-527
18. Stephens LC, Schultheiss TE, Small SM, Ang KK, Peters LJ (1989) Response of parotid gland organ culture to radiation. Radiat Res 120:140-153
19. Pratt NE, Sodicoff M, Liss J, Davis M, Sinesi M (1980) Radioprotection of the rat parotid gland by WR-2721: Morphology at 60 days post-irradiation. Int J Radiat Oncol Biol Phys 6:431-435
20. Bennett CL, Lane D, Stinson T, Glatzel M, Buntzel J (2001) Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: Preliminary results from a randomized phase II clinical trial from Germany. Cancer Invest 19:107-113
21. Hay EM, Thomas E, Hajeer A, Chambers H, Silman AJ (1998) Weak association between subjective symptoms of and objective testing for dry eye and dry mouth: Results from a population based study. Ann Rheum Dis 57:20-24